Amanda Kaza
Cardiovascular Disease · Grand Rapids, MINPI 1760134696
Payments from drug & device makers
Across 290 payments — averaging $21.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- E.r. Squibb & Sons, L.L.C.$708
- Novartis$450
- Johnson & Johnson$361
- Amgen$350
- Merck$339
- plus $3K from 29 others
What the payments were for
- Travel & lodging$85913%
- Food & beverage$5,42885%
- Education$841%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 13 | $1,227 |
| E.r. Squibb & Sons, L.L.C. | 42 | $708 |
| Novartis | 28 | $450 |
| Johnson & Johnson | 19 | $361 |
| Amgen | 18 | $350 |
| Merck | 15 | $339 |
| AstraZeneca(2 entities) | 16 | $304 |
| Novo Nordisk | 12 | $270 |
| Alnylam Pharmaceuticals Inc. | 12 | $257 |
| Bayer | 14 | $256 |
| Boehringer Ingelheim | 11 | $241 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 29 | $237 |
| Actelion Pharmaceuticals US, Inc. | 6 | $168 |
| Pfizer | 7 | $140 |
| Lexicon Pharmaceuticals, Inc. | 8 | $126 |
| Kiniksa Pharmaceuticals International, PLC | 5 | $116 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $100 |
| CSL Behring | 3 | $74 |
| Boston Scientific | 3 | $72 |
| Abiomed | 4 | $72 |
| Vital Connect, Inc | 2 | $66 |
| Esperion Therapeutics, Inc. | 4 | $59 |
| Baxter Healthcare | 3 | $47 |
| Sanofi-aventis U.S. LLC | 2 | $43 |
| Bridgebio Pharma, Inc. | 2 | $41 |
| Atricure, Inc. | 1 | $39 |
| Cardiva Medical, Inc. | 1 | $35 |
| Dexcom, Inc. | 1 | $29 |
| Chiesi USA, Inc. | 1 | $29 |
| Daiichi Sankyo Inc. | 2 | $27 |
| CMP Pharma, Inc. | 1 | $22 |
| Impulse Dynamics (USA) Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Scpharmaceuticals Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYMPLICITY G3$801
- CAMZYOS$247
How this compares
$6,371 in reported general payments places this provider in the 60th percentile of 760 cardiovascular disease providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 87 | $97,823 |
| EntrestoSacubitril/Valsartan | 61 | $63,293 |
| JardianceEmpagliflozin | 52 | $52,551 |
| XareltoRivaroxaban | 13 | $20,522 |
| FarxigaDapagliflozin Propanediol | 26 | $18,452 |
| Repatha SureclickEvolocumab | 15 | $16,987 |
| BrilintaTicagrelor | 24 | $15,761 |
| Metoprolol Succinate | 241 | $5,117 |
| Ranolazine ErRanolazine | 30 | $4,014 |
| Rosuvastatin Calcium | 154 | $3,527 |
| Atorvastatin Calcium | 152 | $2,977 |
| Ezetimibe | 85 | $2,347 |
| Losartan Potassium | 135 | $2,186 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 88 | $1,786 |
| ClopidogrelClopidogrel Bisulfate | 98 | $1,642 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $140 | $97,82387 claims |
| NovartisEntresto | $450 | $63,29361 claims |
| Boehringer IngelheimJardiance | $241 | $52,55152 claims |
| AstraZenecaFarxiga, Brilinta | $304 | $34,21350 claims |
| Johnson & JohnsonXarelto | $361 | $20,52213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 760 cardiovascular disease providers in Michigan.
Other cardiovascular disease in Grand Rapids
- Jihad MustaphaGrand Rapids$1.9M
- Fadi SaabGrand Rapids$430K
- Stanley ChetcutiAnn Arbor$4.3M
- Sandeep KhuranaGrandville$2.3M
- Victor MolesAnn Arbor$2.1M
- Marschall RungeAnn Arbor$1.8M
- Sara SaberiAnn Arbor$1.6M
- Brian OneillDetroit$1.4M
- Vallerie McLaughlinAnn Arbor$1.4M
- Ahmad MizyedYpsilanti$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.